UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant
to Section 13 OR 15(d) of
The
Securities Exchange Act of 1934
Date of Report (Date
of earliest event reported): July
29, 2010
| Natus Medical Incorporated |
| (Exact name of registrant as specified in its charter) |
| Delaware | 000-33001 | 77-0154833 | ||
|
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
| 1501 Industrial Road, San Carlos, California 94070 |
| (Address of principal executive offices) (Zip Code) |
| Registrant's telephone number, including area code: | (650) 802-0400 |
| Not applicable |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02. Results of Operations and Financial Condition.
On July 29, 2010, Natus Medical Incorporated (the “Company”) is issuing a press release and holding a conference call regarding its financial results for the second fiscal quarter of 2010 ended June 30, 2010 and other financial information. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01. Financial Statements and Exhibits.
|
(d) |
Exhibits. |
||
|
Exhibit No. |
Description |
||
| 99.1 | Press release of Natus Medical Incorporated dated July 29, 2010 describing the Company’s results for its second fiscal quarter ended June 30, 2010 and other financial information. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
NATUS MEDICAL INCORPORATED |
|||
|
Date: |
July 29, 2010 |
By: |
/s/ Steven J. Murphy |
|
|
Steven J. Murphy |
||
|
|
Vice President Finance and Chief Financial Officer |
||
Index to Exhibits
|
Exhibit No. |
Description |
| 99.1 |
Press release of Natus Medical Incorporated dated July 29, 2010 describing the Company’s results for its second fiscal quarter ended June 30, 2010 and other financial information. |